Tesofensine 500 mcg – 60 kapsúl

Original price was: 149,80 €.Current price is: 127,33 €.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Research Compound · Capsules

Tesofensine 500 mcg – 60 Capsules

Research-grade compound supplied as 60 pre-portioned capsules, each containing 500 mcg tesofensine (as citrate). A triple monoamine (serotonin / noradrenaline / dopamine) reuptake inhibitor studied in controlled experimental models of appetite regulation and monoamine pharmacology.

Research Use Only
This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity
≥99% (HPLC, third-party tested)
Form
Research capsules
Content per Capsule
500 mcg tesofensine (citrate)
Total per Bottle
60 capsules (30 mg total)
Packaging
Sealed bottle with tamper-evident closure
Storage
Store at room temperature, dry, protected from light
Molecular Formula
C17H23Cl2NO (free base)
Molecular Weight
≈ 328.28 g/mol (free base)
IUPAC Name
(1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
CAS Number
402856-42-2 (free base) / 195875-84-4 (citrate)

Format

Supplied as pre-portioned research capsules — no reconstitution or weighing is required, supporting consistent dosing accuracy in controlled experimental workflows. Keep the bottle sealed and stored at room temperature, dry and protected from light.

Research Overview

Tesofensine is a synthetic small molecule that acts as a triple monoamine reuptake inhibitor, simultaneously targeting the reuptake of serotonin, noradrenaline, and dopamine. In controlled experimental settings it is studied for its effects on appetite and food-reward pathways, monoamine neurotransmitter pharmacology, and metabolic-regulation models. It is frequently used as a reference compound in obesity and reward-related research. No therapeutic or clinical claims are made or implied.

Primary Research Areas

Triple Monoamine Reuptake Inhibition
Used to investigate combined modulation of serotonin, noradrenaline, and dopamine reuptake in pharmacology models.
Appetite & Food-Reward Research
Applied in experimental studies examining food-intake behavior and reward-driven feeding.
Obesity & Metabolic-Syndrome Models
Explored in preclinical models assessing body-weight regulation and metabolic parameters.
Reward, Motivation & Neurological Research
Studied in models of reward, motivation, and monoamine-related neurological pathways.

RELATED PRODUCTS